£119.05

Routledge Defining Drugs: How Government Became the Arbiter of Pharmaceutical Fact

Price data last checked 10 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£119 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 81 days · 81 data points (no recent data)

Historical
Generating forecast…
£136.11 £117.34 £121.44 £125.53 £129.63 £133.72 £137.82 25 April 2026 15 May 2026 04 June 2026 24 June 2026 14 July 2026

Price Distribution

Price distribution over 81 days • 2 price levels

Days at Price
Current Price
51 days · current 30 days 0 13 26 38 51 £119 £136 Days at Price

Price Analysis

Most common price: £119 (51 days, 63.0%)

Price range: £119 - £136

Price levels: 2 different prices over 81 days

Description

Drug-related morbidity and mortality is rampant in contemporary industrial society, despite or perhaps because, government has assumed a critical role in the process by which drugs are developed and approved. Parrish asserts that, as a people, Americans need to understand how it is that government became the arbiter of pharmaceutical fact. The consequences of our failure to understand, he argues, may threaten individual choice and forestall the development of responsible therapeutics. Moreover, if current standards and control continues unabated, the next therapeutic reformation might well make possible the sanctioned commercial exploitation of patients. In Defining Drugs, Parrish argues that the federal government became arbiter of pharmaceutical fact because the professions of pharmacy and medicine, as well as the pharmaceutical industry, could enforce these definitions and standards only through police powers reserved to government. Parrish begins his provocative study by examining the development of the social system for regulating drug therapy in the United States. He reviews the standards that were negotiated, and the tensions of the period between Progressivism and the New Deal that gave cultural context and historical meaning to drug use in American society. Parrish describes issues related to the development of narcotics policy through education and legislation facilitated by James Beal and Edward Kremers, and documents the federal government's evolving role as arbiter of market tensions between pharmaceutical producers, government officials, and private citizens in professional groups, illustrating the influence of government in writing enforceable standards for pharmaceutical therapies. He shows how the expansion of political rights for practitioners and producers has shifted responsibility for therapeutic consequences from individual practitioners and patients to government. This timely and controversial volume is written for the scholar and the compassionate practitioner alike, and a general public concerned with pharmacy regulation in a free society. Review -Defining Drugs documents the evolution of social thought and action about pharmaceuticals in the United States in the 20th century. Written from a free-market perspective, Richard Parrish demonstrates how industry, goverment, and profressional leaders used science to justify the expansion of goverment power over standards and people. The Politicized definition of pharmaceutical fact cemented the foundation of pharmacotherapy in the modern pharmacratic state. Parrish's thesis will affect the current debates on federal power concerning the proper role of pharmacists, physicians, prescription laws, and Medicare prescription benefits; dietary supplements and herbal remedies; and nanotechnologies and pharmacgenomics. Scholary in documentation and persuasive in tone, Defining Drugs is an indispensable contribution to our understanding of the debate about drugs and drug policy.- --Dr. Thomas Szasz, State University of New York -Parrish provides an invaluable analysis of the transformation of pharmaceutical regulation over the past millennium.---Peter Barton Hutt, Esq., Covington and Burling -Defining Drugs is an essential key for the medical profession and any who would understand the drug industry's regulation processes.- --The Midwest Book Review "Defining Drugs documents the evolution of social thought and action about pharmaceuticals in the United States in the 20th century. Written from a free-market perspective, Richard Parrish demonstrates how industry, goverment, and profressional leaders used science to justify the expansion of goverment power over standards and people. The Politicized definition of pharmaceutical fact cemented the foundation of pharmacotherapy in the modern pharmacratic state. Parrish's thesis will affect the current debates on federal power concerning the proper role of pharmacists, physicians, prescription l

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 March 2003
Listed Since
23 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Pharmaceutical Public Policy
96% match

Pharmaceutical Public Policy

CRC Press

£57.51 08 Jul 2026
Government, Big Pharma, and The People: A Century of Dis-Ease
96% match

Government, Big Pharma, and The People: A Century of Dis-Ease

CRC Press

£51.93 02 Jul 2026
Comparative Diagnostic Pharmacology: Clinical and Research Applications in Living-System Models
96% match

Comparative Diagnostic Pharmacology: Clinical and Research Applications in Living-System Models

Wiley-Blackwell

£420.72 13 Jul 2026
Managing the Drug Discovery Process: Insights and advice for students, educators, and practitioners
96% match

Managing the Drug Discovery Process: Insights and advice for students, educators, and practitioners

Woodhead Publishing

£146.36 18 Jun 2026
Transformative Concepts for Drug Design: Target Wrapping
96% match

Transformative Concepts for Drug Design: Target Wrapping

Springer

£89.00 21 Jun 2026
Martin's Physical Pharmacy and Pharmaceutical Sciences
96% match

Martin's Physical Pharmacy and Pharmaceutical Sciences

WOLTERS KLUWER HEALTH

£62.92 11 Jul 2026
Understanding Drugs Markets: An Analysis of Medicines, Regulations and Pharmaceutical Systems in the Global South (Routledge Studies in the Sociology of Health and Illness)
96% match

Understanding Drugs Markets: An Analysis of Medicines, Regulations and Pharmaceutical Systems in the Global South (Routledge Studies in the Sociology of Health and Illness)

Routledge

£43.90 01 Jul 2026
Blankettstrafgesetze und ihre verfassungsrechtlichen Grenzen: 1 (Juridicum - Schriften zum Wirtschaftsstrafrecht, 1)
96% match

Blankettstrafgesetze und ihre verfassungsrechtlichen Grenzen: 1 (Juridicum - Schriften zum Wirtschaftsstrafrecht, 1)

Springer

£48.96 08 Jul 2026
Pharmaceuticals, Corporate Crime and Public Health
96% match

Pharmaceuticals, Corporate Crime and Public Health

Edward Elgar Publishing

£87.85 09 Jul 2026
Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)
96% match

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Edward Elgar Publishing

£100.00 26 Jun 2026
Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health
96% match

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Edward Elgar Publishing

£92.14 15 Jul 2026
Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research
96% match

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

Routledge

£120.00 04 Jul 2026
Handbook of Nonprescription Drugs: An Interactive Approach to Self-care
96% match

Handbook of Nonprescription Drugs: An Interactive Approach to Self-care

Brand: American Pharmacists Association

£97.53 13 Jul 2026
World Pharmaceutical Industry
96% match

World Pharmaceutical Industry

Cengage Learning

£104.00 03 Jul 2026
Leishmaniasis: Biology, Control and New Approaches for Its Treatment
96% match

Leishmaniasis: Biology, Control and New Approaches for Its Treatment

CRC Press

£77.10 15 Jul 2026
Development of Therapeutic Agents Handbook: 8 (Pharmaceutical Development Series)
96% match

Development of Therapeutic Agents Handbook: 8 (Pharmaceutical Development Series)

Wiley

£110.09 09 Jul 2026
Fundamentals of Medicinal Chemistry
96% match

Fundamentals of Medicinal Chemistry

Wiley-Blackwell

£106.99 04 Jul 2026
Pharmacology and the Nursing Process
96% match

Pharmacology and the Nursing Process

Mosby

£79.06 09 Jul 2026
Pharmaceutical Medicine (Oxford Specialist Handbooks)
96% match

Pharmaceutical Medicine (Oxford Specialist Handbooks)

Oxford University Press

£56.99 19 Jun 2026
Global Issues in Pharmaceutical Marketing
96% match

Global Issues in Pharmaceutical Marketing

Routledge

£153.05 15 Jul 2026
The Future of Pharma: Evolutionary Threats and Opportunities
96% match

The Future of Pharma: Evolutionary Threats and Opportunities

Routledge

£136.81 26 Jun 2026
Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants
96% match

Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician Assistants

Elsevier

£92.26 11 Jul 2026
Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)
96% match

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Routledge

£136.81 27 Jun 2026
Global Pharmaceutical Policy
96% match

Global Pharmaceutical Policy

MACMILLAN

£115.44 13 Jul 2026